Mengxiao Zhu
Daping, 400042, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis.
Journal: Developmental cell
Published: September 26, 2024
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance.
Journal: Japanese journal of clinical oncology
Published: May 04, 2023
Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer.
Journal: Cancer science
Published: December 06, 2022
Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: July 05, 2022
Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
Journal: Thoracic cancer
Published: April 26, 2022
First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments.
Journal: Clinical Medicine Insights. Oncology
Published: April 01, 2022
Case Report: Durable Response to the Combination of Brigatinib and Cetuximab Plus Icotinib in a NSCLC Patient Harboring EGFR L858R-T790M-cis-G796S and L718Q Resistance Mutations Following Progression With Osimertinib.
Journal: Frontiers in oncology
Published: February 14, 2022
Stoichioproteomics study of differentially expressed proteins and pathways in head and neck cancer.
Journal: Brazilian journal of biology = Revista brasleira de biologia
Published: March 04, 2021
The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 14, 2020
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 25, 2019
Serial ultra-deep sequencing of circulating tumor DNA reveals the clonal evolution in non-small cell lung cancer patients treated with anti-PD1 immunotherapy.
Journal: Cancer medicine
Published: June 07, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026